FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula , wherein A and V independently represents H or a halogen; Q is absent; R4 independently represents H, a C1-C6 alkyl or C3-C6 cycloalkyl; R7 represents H; and R8 represents a C1-C10 alkyl substituted by OH or C1-C6 alkoxy; or C1-4 alkyl substituted by a 5-6-merous aromatic heterocyclic ring containing 1-2 heteroatoms specified in N and S, wherein the above aromatic heterocyclic ring is optionally substituted by a C1-C10 alkyl; or in -NR7R8, R7 and R8 together with N can form an optionally substituted azacyclic ring containing where applicable an additional heteroatom specified in H, O and S, as a cycle member, optionally substituted by a C1-C10 alkyl, which is substituted by a C1-C6 alkoxy; m is equal to 0; n is equal to 0. The invention also refers to a compound of formula (wherein the substitutes are those as specified in the patient claim), to a pharmaceutical composition containing a therapeutically effective amount of the compounds of formula (VIII), and to a method of treating or relieving a cell-proliferative disorder.
EFFECT: compound of formula (VIII) inhibiting cell proliferation or cell apoptosis.
12 cl, 1 dwg, 14 tbl, 55 ex
Title | Year | Author | Number |
---|---|---|---|
SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS | 2013 |
|
RU2681209C2 |
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT | 2016 |
|
RU2752506C2 |
COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER | 2016 |
|
RU2786570C2 |
METHODS FOR SELECTIVE INTRODUCTION OF PROTECTIVE GROUPS INTO RESORCINOL DERIVATIVES | 2019 |
|
RU2738408C1 |
INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITORS, PREPARATION AND USE THEREOF | 2015 |
|
RU2719428C2 |
N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES | 2006 |
|
RU2428421C2 |
APPLICATION OF ARYL AND HETARYL CARBOXAMIDES AS ENDOPARASITICIDES | 2012 |
|
RU2638830C2 |
HETEROBICYCLIC HEPATITIS C VIRUS (HCV) INHIBITORS | 2006 |
|
RU2405783C2 |
BICYCLIC AGONISTS OF STING INTERFERON GENE STIMULATOR | 2020 |
|
RU2813691C2 |
BICYCLIC AGONISTS OF THE INTERFERON GENE STIMULATOR STING | 2020 |
|
RU2800072C1 |
Authors
Dates
2015-05-10—Published
2008-10-03—Filed